Filippo Angelini

[stopstorm.eu @stopstormEU]

The first EU-wide STAR data registry is now open! 🖥️🎉🙌Want to learn more about the project & what we hope to achieve? Watch our animation: https://t.co/7i5SjqUwl6

#EPeeps #radiotherapy #h2020

[Insel Gruppe @inselgruppe]

@stopstormEU 👏

[Giuseppe Biondi-Zoccai @gbiondizoccai]

In-hospital outcomes in nonagenarian patients undergoing primary percutaneous coronary intervention, by Angelini et al
https://t.co/fKFWUZ27qo
#MinervaCardiologyAngiology
@leonardodeluca @DFCapodanno @Fabri84Dascenzo

[Giornate Cardiologiche Torinesi ed.34 @GTorinesi]

Il Prof. Gaetano De Ferrari presenta le Giornate Cardiologiche Torinesi, gli ospiti e i temi che faranno di questa edizione un evento speciale.
Gaetano De Ferrari https://t.co/x4s23bpG9m via @YouTube
#alwaysTowardsTheFuture
#CardiologiaTorinese
#Mayoclinic

[Gaetano M De Ferrari @GMDeFerrari]

Sodium Nitroprusside in Acute Heart Failure: A Multicenter Historic Cohort Study @SSRN https://t.co/l6oUt4OHrS

We save lives everyday with this old drug which we are trying to resuscitate!!
Join us and we will gain momentum for a trial to give this agent the space it deserves!!

[Giornate Cardiologiche Torinesi ed.34 @GTorinesi]

@GMDeFerrari

[Gaetano M De Ferrari @GMDeFerrari]

Molinette di Torino, grazie all’Intelligenza artificiale si potranno prevedere nuove aritmie https://t.co/KejPLfqKfO

[CardioTomLuscher @TomLuscher]

A fantastic London Postgraduate Course 2021-2022 endet with a touching Graduation Ceremony - 6 modules with the best in HF and outstanding participants - a well trained next generation of HF leaders: Education center of Zurich Heart house - London Heart House at its best!

[Gaetano M De Ferrari @GMDeFerrari]

In just over one month, the working group of myocardial and pericardial disease will meet in Torino. You can send an abstract, including interesting case reports, within tomorrow!! Please circulate and participate!!

[Filippo Angelini @Fil_Angelini]

#acuteheartfailure https://t.co/or5j9ITUst

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Duration and kind of dual antiplatelet therapy for acute coronary syndrome patients: a network meta-analysis, by D'Ascenzo et al
https://t.co/zQhiJUgSxS
#MinervaCardiologyAngiology
@Fabri84Dascenzo @ovidio_def @Fil_Angelini

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis, by Sabouret et al
https://t.co/6RMCcsVLrr
@SABOURETCardio @Fabri84Dascenzo @GiuseppeGalati_ @DLBHATTMD

[SABOURETCardiologist @SABOURETCardio]

A good news and surprise to discover that our collaborative article is online. Thanks for the great contribution to all coauthors obviously @BocchinoPier @FilippoAngelini @Fabri84Dascenzo @GiuseppeGalati_ @fischman_david @DLBHATTMD @gbiondizoccai. #T2D #GLP1RA #SGLT2i

[SABOURETCardiologist @SABOURETCardio]

A long delivery for this #MA (due to hidden COI of some reviewers in our view) but we are happy to publish these data that may help in practice. For this teamwork I add the pics of coauthors ⁦@BocchinoPier⁩ ⁦@Fil_Angelini⁩ F. D’ascenzo

[SABOURETCardiologist @SABOURETCardio]

One good news (in #CardioTwitter not in political field). Our #MA on #GLP1RA vs #SGLT2i is accepted for publication. A team work with @BocchinoPier @FilippoAngelini F. d’Ascenzo @GiuseppeGalati_ Fysekidis,De Ferrari, the MA experts@fischman_david @DLBHATTMD @gbiondizoccai ☀️

[guglielmo gallone @guglielmogallo1]

Impact of sarcopenia on TAVI outcomes - check out our latest work from the Molinette Hospital Heart Team! Multidisciplinary approach is the key @GMDeFerrari @Fabri84Dascenzo @cescobruno https://t.co/4e41AXPyUl

[Andrea Saglietto @AndreaSaglietto]

Check out our new research article regarding left atrial thrombosis in AFib patients undergoing ECV or catheter ablation! @Fil_Angelini @BocchinoPier @Fabri84Dascenzo @mattans5

#AFib #NOAC #LA #LAA #thrombosis

https://t.co/Q3U9afDBAc

[Francesco Bruno @cescobruno]

Our work on FFR evaluation in CABG was cited by the 2021 ACC/AHA guidelines for coronary artery revascularization! Another impressive achievement of a strong team. https://t.co/Prn664efyI @Fabri84Dascenzo @ovidio_def @guglielmogallo1 @AndreaSaglietto @GMDeFerrari @FConrotto

[JACC Journals @JACCJournals]

A meta-analysis of studies finds significant improvement in tricuspid regurgitation (TR) severity and New York Heart Association class after isolated TTVr for significant TR. https://t.co/JjPBS6SFmL

#TR #TTVr #JACCINT #CardioTwitter

[Fabrizio D'Ascenzo @Fabri84Dascenzo]

our group was involved into a Cochrane review!.
https://t.co/lDtDW1XlLI
thanks to @gbiondizoccai who inspired us! @GMDeFerrari @ovidio_def @cescobruno @guglielmogallo1 @franchin_luca @Fil_Angelini